Literature DB >> 31055702

Risk, Overdiagnosis and Ethical Justifications.

Wendy A Rogers1, Vikki A Entwistle2, Stacy M Carter3.   

Abstract

Many healthcare practices expose people to risks of harmful outcomes. However, the major theories of moral philosophy struggle to assess whether, when and why it is ethically justifiable to expose individuals to risks, as opposed to actually harming them. Sven Ove Hansson has proposed an approach to the ethical assessment of risk imposition that encourages attention to factors including questions of justice in the distribution of advantage and risk, people's acceptance or otherwise of risks, and the scope individuals have to influence the practices that generate risk. This paper investigates the ethical justifiability of preventive healthcare practices that expose people to risks including overdiagnosis. We applied Hansson's framework to three such practices: an 'ideal' breast screening service, a commercial personal genome testing service, and a guideline that lowers the diagnostic threshold for hypertension. The framework was challenging to apply, not least because healthcare has unclear boundaries and involves highly complex practices. Nonetheless, the framework encouraged attention to issues that would be widely recognised as morally pertinent. Our assessment supports the view that at least some preventive healthcare practices that impose risks including that of overdiagnosis are not ethically justifiable. Further work is however needed to develop and/or test refined assessment criteria and guidance for applying them.

Entities:  

Keywords:  Ethics; Harm; Overdiagnosis; Risk; Risk evaluation; Uncertainty

Mesh:

Year:  2019        PMID: 31055702     DOI: 10.1007/s10728-019-00369-7

Source DB:  PubMed          Journal:  Health Care Anal        ISSN: 1065-3058


  27 in total

1.  Lessons from the mammography wars.

Authors:  Kerianne H Quanstrum; Rodney A Hayward
Journal:  N Engl J Med       Date:  2010-09-09       Impact factor: 91.245

Review 2.  Overdiagnosis in cancer.

Authors:  H Gilbert Welch; William C Black
Journal:  J Natl Cancer Inst       Date:  2010-04-22       Impact factor: 13.506

3.  Diagnosing overdiagnosis: conceptual challenges and suggested solutions.

Authors:  Bjorn Hofmann
Journal:  Eur J Epidemiol       Date:  2014-06-01       Impact factor: 8.082

4.  Abolishing mammography screening programs? A view from the Swiss Medical Board.

Authors:  Nikola Biller-Andorno; Peter Jüni
Journal:  N Engl J Med       Date:  2014-04-16       Impact factor: 91.245

5.  A definition and ethical evaluation of overdiagnosis.

Authors:  Stacy M Carter; Chris Degeling; Jenny Doust; Alexandra Barratt
Journal:  J Med Ethics       Date:  2016-07-08       Impact factor: 2.903

6.  Quantifying the benefits and harms of screening mammography.

Authors:  H Gilbert Welch; Honor J Passow
Journal:  JAMA Intern Med       Date:  2014-03       Impact factor: 21.873

7.  Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial.

Authors:  Jolyn Hersch; Alexandra Barratt; Jesse Jansen; Les Irwig; Kevin McGeechan; Gemma Jacklyn; Hazel Thornton; Haryana Dhillon; Nehmat Houssami; Kirsten McCaffery
Journal:  Lancet       Date:  2015-02-18       Impact factor: 79.321

8.  Ethical issues raised by thyroid cancer overdiagnosis: A matter for public health?

Authors:  Wendy A Rogers; Wendy L Craig; Vikki A Entwistle
Journal:  Bioethics       Date:  2017-10       Impact factor: 1.898

9.  Public Opinions about Overdiagnosis: A National Community Survey.

Authors:  Ray Moynihan; Brooke Nickel; Jolyn Hersch; Elaine Beller; Jenny Doust; Shane Compton; Alexandra Barratt; Lisa Bero; Kirsten McCaffery
Journal:  PLoS One       Date:  2015-05-20       Impact factor: 3.240

10.  Expanding disease definitions in guidelines and expert panel ties to industry: a cross-sectional study of common conditions in the United States.

Authors:  Raymond N Moynihan; Georga P E Cooke; Jenny A Doust; Lisa Bero; Suzanne Hill; Paul P Glasziou
Journal:  PLoS Med       Date:  2013-08-13       Impact factor: 11.069

View more
  4 in total

1.  Screening is not always healthy: an ethical analysis of health screening packages in Singapore.

Authors:  Mee Lian Wong; Teck Chuan Voo; Sarah Ee Fang Yong
Journal:  BMC Med Ethics       Date:  2022-06-07       Impact factor: 2.834

2.  Breast cancer risk stratification for mammographic screening: A nation-wide screening cohort of 24,431 women in Singapore.

Authors:  Peh Joo Ho; Fuh Yong Wong; Wen Yee Chay; Elaine Hsuen Lim; Zi Lin Lim; Kee Seng Chia; Mikael Hartman; Jingmei Li
Journal:  Cancer Med       Date:  2021-10-28       Impact factor: 4.452

3.  Is the Cure Worse than the Disease? The Ethics of Imposing Risk in Public Health.

Authors:  Diego S Silva; Maxwell J Smith
Journal:  Asian Bioeth Rev       Date:  2022-09-10

Review 4.  Breast Cancer in Asia: Incidence, Mortality, Early Detection, Mammography Programs, and Risk-Based Screening Initiatives.

Authors:  Yu Xian Lim; Zi Lin Lim; Peh Joo Ho; Jingmei Li
Journal:  Cancers (Basel)       Date:  2022-08-30       Impact factor: 6.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.